HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 192 filers reported holding HORIZON PHARMA PLC in Q2 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $18,448,000 | +67.3% | 698,000 | +23.6% | 0.04% | +44.0% |
| Q4 2018 | $11,029,000 | +15.2% | 564,500 | +15.4% | 0.02% | +38.9% |
| Q3 2018 | $9,575,000 | +32.1% | 489,000 | +11.7% | 0.02% | +28.6% |
| Q2 2018 | $7,247,000 | +26.8% | 437,600 | +8.7% | 0.01% | +40.0% |
| Q1 2018 | $5,717,000 | +98.2% | 402,600 | +103.8% | 0.01% | +100.0% |
| Q4 2017 | $2,884,000 | +123.2% | 197,500 | +93.8% | 0.01% | +66.7% |
| Q3 2017 | $1,292,000 | +380.3% | 101,900 | +348.9% | 0.00% | +200.0% |
| Q2 2017 | $269,000 | +1693.3% | 22,700 | +2170.0% | 0.00% | – |
| Q1 2017 | $15,000 | -71.7% | 1,000 | -69.7% | 0.00% | – |
| Q4 2016 | $53,000 | -39.1% | 3,300 | -37.7% | 0.00% | – |
| Q2 2016 | $87,000 | -23.7% | 5,300 | -23.2% | 0.00% | – |
| Q1 2016 | $114,000 | -19.1% | 6,900 | -2.8% | 0.00% | -100.0% |
| Q3 2015 | $141,000 | +69.9% | 7,100 | +195.8% | 0.00% | – |
| Q2 2015 | $83,000 | – | 2,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JABODON PT CO | 187,808 | $4,519,000 | 3.52% |
| KNOTT DAVID M | 50,046 | $1,204,000 | 0.51% |
| CASTLEARK MANAGEMENT LLC | 362,980 | $8,733,000 | 0.34% |
| EAGLE ASSET MANAGEMENT INC | 2,692,100 | $64,771,000 | 0.33% |
| USA FINANCIAL FORMULAS | 15,202 | $402,000 | 0.20% |
| Qtron Investments LLC | 12,274 | $295,000 | 0.18% |
| C WorldWide Group Holding A/S | 491,544 | $11,827,000 | 0.15% |
| Gotham Asset Management, LLC | 207,158 | $4,984,000 | 0.08% |
| Russell Investments Group, Ltd. | 608,977 | $14,652,000 | 0.03% |
| FNY Investment Advisers, LLC | 3,350 | $80,000 | 0.02% |